Patents by Inventor Stephen McCormack

Stephen McCormack has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230140868
    Abstract: The present invention relates to chimeric binding agents and compositions comprising the same. The invention further relates to polynucleotides encoding the chimeric binding agent and vectors and host cells comprising the same. The invention further relates to methods of using the chimeric binding agents to mediate antibody-dependent cellular cytotoxicity of epithelial cancer cells and methods of treating epithelial cell cancers.
    Type: Application
    Filed: April 23, 2021
    Publication date: May 11, 2023
    Inventors: David Cheresh, Sara Weis, Stephen McCormack, Christoph Rader, Hiromi Wettersten
  • Publication number: 20180286860
    Abstract: A split gate power transistor includes a laterally configured power PMOSFET including a doped silicon substrate, a gate oxide layer formed on a surface of the substrate, and a split polysilicon layer formed over the gate oxide layer. The polysilicon layer is cut into two electrically isolated portions, a first portion forming a switching gate positioned over a first portion of a channel region of the substrate, and a second portion forming a static gate formed over a second portion of the channel region and a transition region of the substrate. The static plate also extends over a drift region of the substrate, where the drift region is under a field oxide filled trench formed in the substrate. A switching voltage is applied to the switching gate and a constant voltage is applied to the static gate.
    Type: Application
    Filed: March 28, 2018
    Publication date: October 4, 2018
    Inventors: Frederick Perry Giles, Stephen McCormack, Joel M. McGregor
  • Publication number: 20110115019
    Abstract: A split gate power transistor includes a laterally configured power MOSFET including a doped silicon substrate, a gate oxide layer formed on a surface of the substrate, and a split polysilicon layer formed over the gate oxide layer. The polysilicon layer is cut into two electrically isolated portions, a first portion forming a switching gate positioned over a first portion of a channel region of the substrate, and a second portion forming a static gate formed over a second portion of the channel region and a transition region of the substrate. The static plate also extends over a drift region of the substrate, where the drift region is under a field oxide filled trench formed in the substrate. A switching voltage is applied to the switching gate and a constant voltage is applied to the static gate.
    Type: Application
    Filed: November 13, 2009
    Publication date: May 19, 2011
    Applicant: MAXIM INTEGRATED PRODUCTS, INC.
    Inventors: Frederick Perry Giles, Joel M. McGregor, Stephen McCormack
  • Publication number: 20110113242
    Abstract: A method for securing data on a mobile device includes establishing a remote connection between a server and a mobile device, receiving at the server a directory listing from the mobile device indicating files and folders stored on the mobile device, selecting one or more files or folders for securing on the mobile device, and transmitting from the server a secure command to the mobile device instructing the mobile device to secure the selected one or more files or folders. A system including a server and a mobile device can perform the method.
    Type: Application
    Filed: June 9, 2010
    Publication date: May 12, 2011
    Applicant: Beyond Encryption Limited
    Inventor: Stephen McCormack
  • Publication number: 20070255237
    Abstract: Implantable drug delivery systems target delivery of small volumes of drugs to specific tissues. In some cases, a drug delivery system includes an implantable osmotic pump connected to a drug-containing housing, with that housing connected to a needle, cochlear implant or other type of component for ultimate delivery to the target tissue. In some implementations, a subcutaneous port receives a fluid from an external pump. The port is connected to a needle or other component for delivery of one or more drugs to the target tissue. Both solid and liquid drug formulations can be used. In embodiments using solid drugs, a separate drug vehicle (such as saline) can be used to dissolve a portion of the solid drug, with the drug-loaded vehicle then delivered to the target tissue.
    Type: Application
    Filed: May 1, 2006
    Publication date: November 1, 2007
    Applicant: NeuroSystec Corporation
    Inventors: Thomas Lobl, Stephen McCormack, Anna Nagy, Jacob Pananen, John Schloss
  • Publication number: 20060264897
    Abstract: An apparatus may include a needle for sustained delivery of drugs and other agents to the inner ear or other tissues of a human or an animal. The needle can include an insertion stop, and can be placed through the round window membrane or through a surgically-prepared hole in a bone. The needle can be in fluid communication with a port and/or with a micro-infusion or osmotic pump. A cochlear implant electrode can be used instead of a needle.
    Type: Application
    Filed: January 24, 2006
    Publication date: November 23, 2006
    Applicant: NeuroSystec Corporation
    Inventors: Thomas Lobl, Stephen McCormack, Thomas Lenarz, John Schloss, Anna Nagy, Jacob Pananen
  • Publication number: 20060205789
    Abstract: Improved formulations of gacyclidine for direct administration to the inner or middle ear.
    Type: Application
    Filed: March 6, 2006
    Publication date: September 14, 2006
    Applicant: NeuroSystec Corporation
    Inventors: Thomas Lobl, John Schloss, Stephen McCormack, Anna Nagy, Jacob Pananen
  • Patent number: 6395591
    Abstract: An integrated circuit fabrication process includes a selective substrate implant process to effectively decouple a first power supply connection from a second power supply connection while providing immunity against parasitic effects. In one embodiment, the selective substrate implant process forms heavily doped p-type regions only under P-wells in which noise producing circuitry are built. The noisy ground connection for these P-wells are decoupled from the quiet ground connection for others P-wells not connected to any heavily doped regions and in which noise sensitive circuitry are built. The selective substrate implant process of the present invention has particular applications in forming CMOS analog integrated circuits where it is important to decouple the analog ground for sensitive analog circuitry from the often noisy digital grounds of the digital and power switching circuitry.
    Type: Grant
    Filed: December 7, 2000
    Date of Patent: May 28, 2002
    Assignee: Micrel, Incorporated
    Inventors: Stephen McCormack, Martin Alter, Robert S. Wrathall, Carlos Alberto Laber